Navigation Links
Alexza Pharmaceuticals to Present at Jefferies 2010 Global Life Sciences Conference
Date:6/3/2010

drug is quickly absorbed through the lungs into the bloodstream, providing speed of therapeutic onset that is comparable to intravenous administration, but with greater ease, patient comfort and convenience.  

AZ-004 (Staccato loxapine) is Alexza's lead program, which is being developed for the rapid treatment of agitation in schizophrenic or bipolar disorder patients.  Alexza has completed and announced positive results from both of its AZ-004 Phase 3 clinical trials, submitted a New Drug Application  in December 2009, and has a Prescription Drug User Fee Act (PDUFA) goal date of October 11, 2010.  In February 2010, Alexza established a partnership with Biovail Laboratories International SRL, a subsidiary of Biovail Corporation, to develop and commercialize AZ-004 in the U.S. and Canada.    

Alexza has completed an end-of-Phase 2 meeting with the FDA for AZ-001 (Staccato prochlorperazine) and has completed two Phase 2 studies with AZ-104 (Staccato loxapine, low-dose). Both product candidates are being developed for the acute treatment of migraine headache.  

AZ-002 (Staccato alprazolam) has completed Phase 1 testing and one Phase 2a proof-of-concept clinical trial.  Product candidates that have completed Phase 1 testing are AZ-003 (Staccato fentanyl) for the treatment of breakthrough pain, and AZ-007 (Staccato zaleplon) for the treatment of insomnia.  More information, including this and past press releases from Alexza, is available online at www.alexza.com'/>"/>

SOURCE Alexza Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Alexza Secures $25 Million Committed Equity Financing Facility With Azimuth Opportunity, Ltd.
2. Alexza Pharmaceuticals to Present at The Ninth Annual JMP Securities Research Conference
3. Alexza Executes $15 million Working Capital Loan with Hercules Technology Growth Capital, Inc.
4. Alexza Pharmaceuticals Files Shelf Registration Statement
5. Alexza to Announce 2010 First Quarter Financial Results on Monday, May 10, 2010
6. Alexza Reports 2009 Fourth Quarter and Full Year Financial Results and Provides General Corporate Update
7. Alexza Pharmaceuticals Promotes Mark K. Oki to Vice President, Finance and Controller
8. Alexza Pharmaceuticals to Host 2010 Investor/Analyst Day on Thursday, February 18, 2010
9. Alexza Announces AZ-004 (Staccato(R) Loxapine) PDUFA Goal Date of October 11, 2010
10. Alexza Announces Submission of AZ-004 (Staccato(R) Loxapine) NDA
11. Alexza Pharmaceuticals to Present at the 21st Annual Piper Jaffray Health Care Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2014)... "Australia Capsule Endoscopy Systems Market Outlook to 2020″, provides ... market. The report provides value, in millions of US ... dollars) within market segments: Photo - ... , Capsule Endoscopy Data Recorders , Capsule Endoscopy ... shares and distribution shares data for each of these ...
(Date:7/25/2014)... 25, 2014  Smile Train and its technology partner ... Virtual Surgery Simulator among leading global health innovations in ... in Washington, D.C. at The ... "Smile Train is honored to be represented ... of innovators in health and medicine that TEDMED unites ...
(Date:7/25/2014)... COSTA MESA, Calif. , July 25, 2014 /PRNewswire-iReach/ ... Peter Nieto as the new Vice President ... industry for over 30 years in a number of ... CROs in the industry. These positions were primarily related ... has obtained over the past 30 years makes him ...
Breaking Medicine Technology:Australia Capsule Endoscopy Systems Market Analysis and Forecast to 2020 2Australia Capsule Endoscopy Systems Market Analysis and Forecast to 2020 3Australia Capsule Endoscopy Systems Market Analysis and Forecast to 2020 4Australia Capsule Endoscopy Systems Market Analysis and Forecast to 2020 5Smile Train and BioDigital Selected to Showcase Virtual Surgery Simulator in The Hive at TEDMED 2014 2Smile Train and BioDigital Selected to Showcase Virtual Surgery Simulator in The Hive at TEDMED 2014 3Contract Research Organization WCCT Global Welcomes Peter Nieto as Vice President of Business Development 2
(Date:7/28/2014)... Top Northridge dentist , Dr. Farshid Ariz, is ... new dentist can be an intimidating experience. Many people struggle ... and worry about how they will connect with a new ... concerns and dental needs and works to ensure that each ... special coupon can help patients get the treatments they need ...
(Date:7/28/2014)... Pittsburgh, PA (PRWEB) July 28, 2014 "I ... slings were ineffective," said an inventor from Sunnyvale, Calif. "When ... The slings on the market are cumbersome and require too ... alternative." , She developed the Multiple Functioning Vest to improve ... shoulder and arm so that they heal properly. This helps ...
(Date:7/28/2014)... HealthDay Reporter FRIDAY, July 25, ... insurance this year will face fines of up to $2,448 ... Internal Revenue Service says. The Obama administration on Thursday ... some Americans will owe for failing to have health insurance. ... national average premium for a bronze-level health plan. ...
(Date:7/28/2014)... Glidewell Laboratories announced today that ... passed the five-year mark in clinical usage, and have ... prescribed by US dentists. , Even as BruxZir Solid ... results from respected clinical studies, many dentists expressed the ... extended years of clinical service before they would elect ...
(Date:7/28/2014)... 2014 Scientists in Japan have completed ... blood test for the asbestos cancer mesothelioma. Surviving Mesothelioma ... Click here to read it now. , ... Juntendo University Graduate School of Medicine say a new ... step above the old test. , “Particularly for ...
Breaking Medicine News(10 mins):Health News:Northridge Dentist, Dr. Farshid Ariz, is Now Offering a $100 Coupon for New Patients 2Health News:IRS Caps Fines on Uninsured Americans at $12K for Family of 5 2Health News:BruxZir® Solid Zirconia Surpasses Five Years of Clinical Use 2Health News:Test Results Look Promising for New Mesothelioma Blood Test, According to Surviving Mesothelioma 2
... Dec. 17 PureCart Systems LLC, announces,the launch of ... system for healthcare facilities. The system, which can ... equipment, patient beds and,rooms, provides a one-step, hospital-grade disinfectant ... require wiping or rinsing. , ...
... 17 EyeScience Labs announces the,availability of its advanced ... eye syndrome at CVS Pharmacy stores ( www.cvs.com ),nationwide. ... http://www.newscom.com/cgi-bin/prnh/20081217/CLW029-a ) , ... This marks the first time EyeScience Macular ...
... Imbach, Former Vice-President of Revenue and Customer Operations at LinkedIn Named ... Design at Yahoo! Named Product Fellow , ... Mountain ... the industry leader in personal genetics , announced today that ...
... receptor controls blood pressure, study shows , , WEDNESDAY, Dec. ... individuals tend to have high blood pressure, but now ... explain that link. , In findings published in the ... Journal of Medicine , Sadaf Farooqi, of the University ...
... In study, those with pulmonary clots saw benefit, , , ... that giving the clot-dissolving drug tenecteplase (TKNase) to people ... the drug, a form of tissue plasminogen activator (tPA), ... haven,t given up on the idea. , "In specific ...
... woman,s face, physicians say , , WEDNESDAY, Dec. 17 (HealthDay ... has completed the nation,s first near-total face transplant. , ... 80 percent of the skin surface of her face, ... essentially everything except the upper eyelids, forehead, lower ...
Cached Medicine News:Health News:PureCart Systems LLC Develops a Portable Disinfecting System for the Healthcare Industry 2Health News:EyeScience's New Ocular Nutrition Supplements Available at CVS Stores 2Health News:Silicon Valley Veterans Sarah Imbach and Larry Tesler Join 23andMe Management Team 2Health News:Silicon Valley Veterans Sarah Imbach and Larry Tesler Join 23andMe Management Team 3Health News:Silicon Valley Veterans Sarah Imbach and Larry Tesler Join 23andMe Management Team 4Health News:Study Finds Molecular Link Between Obesity, Hypertension 2Health News:Study Finds Molecular Link Between Obesity, Hypertension 3Health News:Clot Dissolver Doesn't Boost Survival in Cardiac Arrest Patients 2Health News:Clot Dissolver Doesn't Boost Survival in Cardiac Arrest Patients 3Health News:Doctors Describe First U.S. Face Transplant 2Health News:Doctors Describe First U.S. Face Transplant 3Health News:Doctors Describe First U.S. Face Transplant 4
True/Fix Distal Femoral Nail System...
... cement youre using, the Vortex Vacuum Mixer is ... is stirring up traditional vacuum mixers. The ergonomically ... time. The time-saving crank three revolutions every ... effort and less stirring, cutting down on the ...
... Simple, cost-effective microfiltration for your ... autotransfusion also brings you an easy ... safety of microfiltration for a variety ... or postoperative applications, autologous or homologous ...
... use; perfect tool with power and endurance. ... user fatigue. Internally lubricated for longer serivce. ... it will not break if dropped. Hex ... life by 50% compared to similar competitive ...
Medicine Products: